Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00812838 · ClinicalTrials.gov registry record · Phase 2

H-22411: BOTOX® for Peyronie's Disease

A Phase 2 study of Peyronie's Disease, sponsored by Mohit Khera.

Completed
Registry status
Phase 2
Development phase
12
Enrollment target
1
Study location

NCT00812838 is a Phase 2 study of Peyronie's Disease that has completed, run by Mohit Khera. The registered enrollment target is 12 participants, below the 188-participant average among 5 other Peyronie's Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00812838, a Phase 2 study of Peyronie's Disease, has completed, sponsored by Mohit Khera.

COMPLETED
Registry status
Phase 2
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Peyronie's disease is a condition in which a plaque, or hard lump, forms on the penis. It causes hardened tissue, pain, and an abnormal bending in the penis. These symptoms are more severe during an erection. Significant bending of the penis can result in pain, poor erections, and an inability to engage in sexual intercourse. This disease affects about 3% of the male population. The average age of onset of this disease is 57 years old. The cause of the disease is unknown. However, many believe that it may be due to trauma to the penis (such as injury or extremely vigorous sexual activity).

Conditions Studied

Peyronie's Disease

Interventions

  • DRUG 100 units of Botulinum Toxin Type A
  • OTHER Preservative free normal saline
  • DRUG 100 units Botulinum Toxin A

Study Locations (1)

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2009-08-07
Est. Completion 2019-01-15
Phase Phase 2

Sponsor

Mohit Khera

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00812838

The ClinicalTrials.gov registry entry for NCT00812838 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 5 other Peyronie's Disease trials with a reported enrollment target (94% lower). The listed sponsor is Mohit Khera, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peyronie's Disease appearing as the primary indexed condition, and to 3 interventions - of which 100 units of Botulinum Toxin Type A is the first listed.

NCT00812838 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00812838 about?

NCT00812838 is a clinical study titled "H-22411: BOTOX® for Peyronie's Disease". Peyronie's disease is a condition in which a plaque, or hard lump, forms on the penis. It causes hardened tissue, pain, and an abnormal bending in the penis. These symptoms are more severe during an erection. Significant bending of the penis can result in pain, poor erections, and an inability to en...

What is the current status of trial NCT00812838?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2009-08-07. Estimated completion is 2019-01-15.

What conditions does trial NCT00812838 study?

This clinical trial studies the following conditions: Peyronie's Disease.

What interventions are being tested in trial NCT00812838?

The interventions under investigation include: 100 units of Botulinum Toxin Type A (DRUG), Preservative free normal saline (OTHER), 100 units Botulinum Toxin A (DRUG).

Who is sponsoring clinical trial NCT00812838?

This trial is sponsored by Mohit Khera, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00812838 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Peyronie's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Peyronie's Disease

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.